Dr Jemma Longley

BM MRCP PhD

NIHR Clinical Lecturer: Medical Oncology

Connect with Jemma

Email: jl36g15@soton.ac.uk

Publications

4 publications

Page 1 of 1

HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy

Khiyam Hussain, Rena Liu, Rosanna C G Smith, Kri T J Müller, Mohammadmersad Ghorbani, Sofia Macari, Kirstie L S Cleary, Robert J Oldham, Russell B Foxall, Sonya James, Steven G Booth, Tom Murray, Lekh N Dahal, Chantal E Hargreaves, Robert S Kemp, Jemma Longley, James Douglas, Hannah Markham, Serena J Chee, Richard J Stopforth, Ali Roghanian, Matthew J Carter, Christian H Ottensmeier, Bjorn Frendéus, Ramsey I Cutress, Ruth R French, Martin J Glennie, Jonathan C Strefford, Stephen M Thirdborough, Stephen A Beers & Mark S Cragg, 2022, Journal of Experimental and Clinical Cancer Research, 41(131), 131

DOI: 10.1186/s13046-022-02294-5

Type: article

Phase I study of the novel Enhancer of Zeste Homolog 2 (EZH2) inhibitor GSK2816126 in patients with advanced hematologic and solid tumors

Timothy A. Yap, Jane N. Winter, Lisa Giulino-Roth, Jemma Longley, Juanita Lopez, Jean-Marie Michot, John P. Leonard, Vincent Ribrag, Michael T. McCabe, Caretha L. Creasy, Melissa Stern, Teodora Pene Dumitrescu, Xiaowei Wang, Steve Frey, Jennifer Carver, Thierry Horner, Choon Oh, Ahmed Khaled, Arindam Dhar & Peter W.M. Johnson, 2019, Clinical Cancer Research

DOI: 10.1158/1078-0432.CCR-18-4121

Type: article

Options for first line therapy of Hodgkin lymphoma

Jemma Longley & Peter W.M. Johnson, 2019, Hematological Oncology, 37(S1), 82-86

DOI: 10.1002/hon.2597

Type: article

Current treatment paradigms for advanced stage Hodgkin lymphoma

Jemma Longley & Peter W.M. Johnson, 2018, British Journal of Haematology

DOI: 10.1111/bjh.15622

Type: article